GENE ONLINE|News &
Opinion
Blog

2022-06-23| PolicySpecial

America’s Ongoing Battle For Lower Insulin Prices

by Reed Slater
Share To
The cost of healthcare in America is astronomical, and insulin prices are a heavy burden on millions of Americans each month. In March, the U.S. House of Representatives passed the Affordable Insulin Now Act to cap insulin prices for insured individuals to $35 a month. The bill appears optimistic for people with diabetes, but the text raises questions about who will actually benefit from lower insulin prices and who may have to pay the same as they have been.
Why Insulin Is A Focal Point For Legislation

Insulin is used to treat diabetes by helping blood sugar enter the body’s cells to create energy. It also signals the liver to store blood sugar for later use, which helps regulate normal organ function. Without insulin, patients with diabetes can develop problems like heart disease, vision loss, and kidney disease. 

GO Prime with only $1.49 now

LATEST
Rebyota Passes Through FDA To Become First Approved Fecal Microbiota Product
2022-12-05
RemeGen Presented New Data Updates on Telitacicept for SLE and primary Sjogren’s syndrome at ACR Convergence 2022
2022-12-05
EMA Urges Pholcodine’s Removal from European Market Following Safety Study
2022-12-05
Lynk Pharmaceuticals Announces First Patient Dosed in Phase Ⅱ Clinical Study of LNK01003 in Patients with Ulcerative Colitis
2022-12-04
Cure Brain Cancer Foundation Rings Nasdaq Opening Bell, Announces U.S. Expansion
2022-12-02
Focus-X Therapeutics, a Viva Biotech Portfolio Company, Successfully Reached an Acquisition Agreement with Full-Life Technologies
2022-12-02
Pfizer To Invest $1.26 Billion In Irish Plant, Forms New Vant Company Targeting Inflammation
2022-12-02
EVENT
2022-12-10
64TH ASH ANNUAL MEETING & EXPOSITION
New Orleans, USA
2022-12-14
BIOHK2022
Hong Kong, China
2022-12-21
Avatar Medicine Forum
Online
2023-01-07
7th Asia Microbiome Conference
Taipei, Taiwan
Scroll to Top

Create an account with us now to say goodbye to all the pop-ups!